Biomimicry is in its earliest stages and is being considered in the realm of tissue engineering. If arterial implants are to limit neointimal thickening, purely passive structures cannot succeed. Bioactivity must be present, either by pharmacologic intervention or by fabricating a 'living stent' that contains active cellular material. As tissue engineering evolves, useful solutions will emerge from applying this knowledge directly to vascular biologic problems resulting from angioplasty, stenting, and vascular prosthesis research.
|Original language||English (US)|
|Number of pages||6|
|Journal||Seminars in interventional cardiology : SIIC|
|State||Published - Jan 1 1998|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine